SCHEMBL20864439

SCHEMBL20864439

O=C(O)c1c(O)c(=O)n(Cc2cnn(Cc3ccnnc3)c2)c2ccsc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ERCC5 P28715 19/20 1.00
▸ FEN1 P39748 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29805009 1.00 ERCC5 (1.00) ERCC5FEN1
SCHEMBL20864115 0.90 ERCC5 (1.00) ERCC5FEN1
SCHEMBL20864120 0.88 ERCC5 (1.00) ERCC5FEN1
SCHEMBL29805017 0.88 ERCC5 (1.00) ERCC5FEN1
SCHEMBL20864302 0.88 ERCC5 (1.00) ERCC5FEN1
SCHEMBL20864251 0.87 ERCC5 (1.00) ERCC5FEN1
SCHEMBL20864207 0.87 ERCC5 (0.82) ERCC5FEN1
SCHEMBL20864226 0.85 ERCC5 (0.85) ERCC5FEN1
SCHEMBL25053700 0.85 ERCC5 (0.79) ERCC5
SCHEMBL20856854 0.84 ERCC5 (1.00) ERCC5FEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11584755-B2 Dihydrothieno[3,2-b]pyridine compounds IDEAYA BIOSCIENCES, INC. (US) 2023-02-21 — — US disclosed
WO-2019067442-A1 DIHYDROTHIENO[3,2-b]PYRIDINE COMPOUNDS IDEAYA BIOSCIENCES, INC. (US) 2019-04-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11584755-B2 Dihydrothieno[3,2-b]pyridine compounds DHFR, CYC1, CYCS ERCC5 3889/4885FEN1 3399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback